Scopus Biopharma Inc reports results for the quarter ended in June - Earnings Summary

Scopus Biopharma

16/08/2021 14:47

* Scopus Biopharma Inc  SCPS.OQ  reported a quarterly adjusted
loss of 97 cents​​ per share for the quarter ended in June. The
lone analyst forecast for the quarter was for a loss of 23 cents
per share.
* Reported revenue was zero​;  analysts expected zero. 
* Scopus Biopharma Inc's reported EPS for the quarter was a loss
of 97 cents​.
* The mean earnings estimate of analysts had fallen by
about 155.6% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Scopus Biopharma Inc shares had fallen by 36.6% this
quarter and lost 69.5% so far this year.
* The company reported a quarterly loss of $15.63 million.
* Wall Street's median 12-month price target for Scopus
Biopharma Inc is $20.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 16 at 01:47 p.m.  ​All
figures in US dollars unless otherwise stated